News

News

Acupuncture is no better than sham acupuncture at alleviating side effects from aromatase inhibitors in breast cancer patients, a new trial has found.

About half of the raw chicken breasts in a nationwide sampling carried antibiotic-resistant bacteria, a U.S. consumer group said on Thursday, calling for stricter limits on use of the medicines on livestock.

Endemic measles, rubella, and congenital rubella syndrome (CRS) have been eliminated from the U.S. for more than a decade, but occasional cases continue to appear, researchers say.

Although almost all transthoracic echocardiograms (TTEs) were deemed appropriate, only 1 in 3 resulted in an active change in the patient’s care and about 1 in 5 resulted in no change in care, according to results of a recent study [JAMA Intern Med. 2013;173:1600-1607].

A new type of nanoparticle that can be absorbed through the digestive tract would allow patients to take pills instead of receiving injections for the treatment of several common diseases and could potentially improve therapy compliance, suggests new research.

A new study from researchers at Yale University has found that a single dose of intranasal oxytocin impacts brain activity in children with autism spectrum disorder (ASD).

Adding the histone deacetylase inhibitor vorinostat (Zolinza) to standard immunoprophylaxis against acute graft-versus-host disease (GVHD) during bone marrow transplant reduced the overall rate of the complication, said a recent study.

Novo Nordisk received European Union marketing authorization for its recombinant coagulation factor VIII drug NovoEight (turoctocog alfa) in November, the Danish pharmaceutical company said on Monday.

Individuals who take formulations of drugs containing sodium have a significantly increased risk of suffering adverse cardiovascular events compared with those who take standard formulations of the same drugs, according to a new study.

British drugmaker Shire's dry eye drug lifitegrast reduced patient-reported symptoms of eye dryness in a late-stage trial - the first drug to do so in a phase III setting - but it missed a second target that measured signs of the disease based on corneal staining.